Quality of life outcomes in patients with anal cancer after combined radiochemotherapy

Strahlentherapie und Onkologie

Volumn 187, Issue 3, 2011, Pages 175-182

  Welzel, Grit ^a   Hägele, Verena ^a   Wenz, Frederik ^a   Mai, Sabine Kathrin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anal cancer; Predictors; Quality of life; Radiochemotherapy

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ANUS CANCER; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTINUOUS INFUSION; DIARRHEA; DRUG WITHDRAWAL; EMOTION; EORTC QLQ C30 QUESTIONNAIRE; EORTC QLQ C38 QUESTIONNAIRE; FATIGUE; FEMALE; FINANCIAL MANAGEMENT; FOLLOW UP; GERMANY; HEALTH CARE COST; HUMAN; LENT SOMA SCALE; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION SICKNESS; RATING SCALE; SKIN TOXICITY; SOCIAL INTERACTION; SYMPTOM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; ANUS TUMOR; CANCER STAGING; CLASSIFICATION; DAILY LIFE ACTIVITY; HEALTH STATUS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FATIGUE; FEMALE; FLUOROURACIL; GERMANY; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 79955666391     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2175-5     Document Type: Article

References (47)

1. Allal AS, Sprangers MAG, Laurencet F, et al. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 1999;80:1588-94. (Pubitemid 29308641)
2. Arndt V, Merx H, Stegmaier C, et al. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol 2004;22:4829-36.
3. Arndt V, Stegmaier C, Ziegler H, et al. A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer 2006;107:2496-503. (Pubitemid 44748535)
4. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9. (Pubitemid 27209535)
5. Bischoff A, Marnitz S, Kohler C, et al. Complete remission after neoadjuvant chemoradiation in a stage IV vulvar cancer patient. Strahlenther Onkol 2008;184:421-5.
6. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18:743-53. (Pubitemid 30106604)
7. Broeckel JA, Jacobsen PB, Horton J, et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998;16:1689-96. (Pubitemid 28234711)
8. Cella D, Davis K, Breitbart W, et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:3385-91. (Pubitemid 32642191)
9. Cummings BJ, Keane TJ, O'Sullivan B, et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991;21:1115-25.
10. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000;5:353-60.
11. Das P, Cantor SB, Parker CL, et al. Long-term quality of life after radiotherapy for the treatment of anal cancer. Cancer 2010;116:822-9.
12. Engel J, Kerr J, Schlesinger-Raab A, et al. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 2003;238:203-13. (Pubitemid 38174494)
13. European Organisation for Research and Treatment of Cancer. EORTC QLQ-C30. (http://groups.eortc.be/qol/questionnaires-qlqc30.htm).
14. Fayers PM, Aaronson NK, Bjordal K, et al. EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels: EORTC Quality of Life Group, 2001:86
15. Ferrigno R, Nakamura RA, Dos Santos Novaes PER, et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 2005;61:1136-42. (Pubitemid 40340908)
16. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2527-39. (Pubitemid 26300120)
17. Fokas E, Wacker U, Gross M, et al. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after highdose radiotherapy? Strahlenther Onkol 2009;185:235-40.
18. Fraunholz I, Rabeneck D, Weiß C, et al. Combined-modality treatment for anal cancer: current strategies and future directions. Strahlenther Onkol 2010;186:361-6.
19. Ganz PA, Rowland JH, Desmond KA, et al. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-14. (Pubitemid 28135592)
20. Geinitz H, Thamm R, Scholz C, et al. Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer. Strahlenther Onkol 2010;186:46-52.
21. Henzel M, Hamm K, Sitter H, et al. Comparison of stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neurinomas according to 3-D tumor volume shrinkage and quality of life. Strahlenther Onkol 2009;185:567-73.
22. Hughes LL, Rich TA, Delclos L, et al. Radiotherapy for anal cancer: experience from 1979-1987. Int J Radiat Oncol Biol Phys 1989;17:1359-61.
23. Jephcott CR, Paltiel C, Hay J. Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors. Clin Oncol (R Coll Radiol) 2004;16:530-5. (Pubitemid 39517661)
24. John M, Flam M, Palma N. Ten-year results of chemoradiation for anal cancer: focus on late morbidity. Int J Radiat Oncol Biol Phys 1996;34:65-9. (Pubitemid 26019955)
25. Johnson LG, Madeleine MM, Newcomer LM, et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004;101:281-8. (Pubitemid 38890830)
26. Klemm P, Miller MA, Fernsler J. Demands of illness in people treated for colorectal cancer. Oncol Nurs Forum 2000;27:633-9.
27. Mai S, Welzel G, Haegele V, et al. The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer. Radiation Oncology 2007;2:30.
28. Mai SK, Welzel G, Hermann B, et al. Long-term outcome after combined radiochemotherapy for anal cancer - retrospective analysis of efficacy, prognostic factors, and toxicity. Onkologie 2008;31:251-7. (Pubitemid 351744825)
29. Mai SK, Welzel G, Hermann B, et al. Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced? Strahlenther Onkol 2009;185:254-9.
30. Mitchell SE, Mendenhall WM, Zlotecki RA, et al. Squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2001;49:1007-13. (Pubitemid 32184606)
31. Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17:354-56.
32. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16:139-44. (Pubitemid 28041591)
33. Peiffert D, Giovannini M, Ducreux M, et al. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study. Ann Oncol 2001;12:397-404. (Pubitemid 32288698)
34. Provencher S, Oehler C, Lavertu S, et al. Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma. Radiation Oncology 2010;5:41.
35. Ramsey SD, Andersen MR, Etzioni R, et al. Quality of life in survivors of colorectal carcinoma. Cancer 2000;88:1294-303. (Pubitemid 30155164)
36. Rao AV, Cohen HJ. Fatigue in older cancer patients: etiology, assessment, and treatment. Semin Oncol 2008;35:633-42.
37. Roscoe JA, Kaufman ME, Matteson-Rusby SE, et al. Cancer-related fatigue and sleep disorders. Oncologist 2007;12:35-42.
38. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37:1345-51. (Pubitemid 32588744)
39. Seegenschmiedt MH (ed) Nebenwirkungen in der Onkologie. Internationale Systematik und Dokumentation. Berlin: Springer, 1998.
40. Sobin LH, Wittekind CH. TNM classification of malignant tumors. 5th ed. New York: John Wiley& Sons, Inc., 1997.
41. Tournier-Rangeard L, Mercier M, Peiffert D, et al. Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol 2008;87:391-97.
42. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348:1049-54.
43. Uronis HE, Bendell JC. Anal Cancer: an Overview. Oncologist 2007;12:524-34. (Pubitemid 350012115)
44. Vinokur AD, Threatt BA, Vinokur-Kaplan D, et al. The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer 1990;65:1242-54. (Pubitemid 20072065)
45. Vordermark D, Sailer M, Flentje M, et al. Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiother Oncol 1999;52:239-43. (Pubitemid 29486643)
46. Wenzel LB, Fairclough DL, Brady MJ, et al. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 1999;86:1768-74. (Pubitemid 29513046)
47. Wright EP, Kiely MA, et al. Social problems in oncology. Br J Cancer 2002;87:1099-104. (Pubitemid 35418104)